Belviq Users With Cancer May Qualify to File a Lawsuit

Consumers who used the weight loss drugs Belviq or Belviq XR and were diagnosed with cancer may qualify to file a lawsuit and receive compensation for their illness. Several lawsuits by patients who were diagnosed with cancer have been filed against Eisai Inc. and Arena Pharmaceuticals — the manufacturers of Belviq — after the weight loss drug was recalled by the FDA. (more…)

By |2020-10-19T16:50:28+00:00September 30th, 2020|Belviq|Comments Off on Belviq Users With Cancer May Qualify to File a Lawsuit

Belviq lawsuits allege weight loss drug linked to increased cancer risk

The manufacturers of the weight loss drug Belviq (lorcaserin) — Eisai Inc. and Arena Pharmaceuticals — are facing several lawsuits over allegations that the medication is linked to an increased cancer risk. Patients who used Belviq to lose weight and have been diagnosed with cancer may qualify to take legal action and receive compensation for their injuries. (more…)

By |2020-10-19T16:49:19+00:00August 26th, 2020|Belviq|Comments Off on Belviq lawsuits allege weight loss drug linked to increased cancer risk

Class action lawsuit alleges Eisai, Arena hid cancer risk of Belviq weight loss drug

Eisai Inc. and Arena Pharmaceuticals — the makers of the drugs Belviq and Belviq XR (lorcaserin) — face a class action lawsuit alleging that the weight loss drugs increase the cancer risk of patients who used them. The lawsuits, filed in March at the U.S. District Court in White Plains, New York, seeks class action status on behalf of patients who used Belviq for weight loss and were diagnosed with cancer. (more…)

By |2020-10-22T14:54:42+00:00April 28th, 2020|Belviq|Comments Off on Class action lawsuit alleges Eisai, Arena hid cancer risk of Belviq weight loss drug

FDA orders recall of Belviq weight loss drug after study finds increased cancer risk

The U.S. Food and Drug Administration has requested that Eisai Inc., the manufacturer of the weight loss drug Belviq, recall the drug after a study found that it could increase the risk of developing pancreatic cancer, colorectal cancer, or lung cancer. (more…)

By |2020-10-19T16:40:08+00:00April 27th, 2020|Belviq|Comments Off on FDA orders recall of Belviq weight loss drug after study finds increased cancer risk